New

Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

PBPHvsIXJETF Comparison

ETF 1
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
-0.57%
VS
ETF 2
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
-0.13%

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. iShares Global Healthcare ETF (IXJ) is part of the Global Large Cap segment. PBPH's top 3 sector exposures are Health Care and Consumer Staples. In contrast, IXJ's top sector exposures are Health Care and Consumer Discretionary.Consumer Staples,  PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.4% for IXJ. PBPH is down -2.73% year-to-date (YTD) with +$787M in YTD flows. IXJ performs worse with -6.67% YTD performance, and -$729M in YTD flows. Run a side-by-side ETF comparison of PBPH and IXJ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBPH vs IXJ performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-40 M-20 M0 M20 M40 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/28/2026
1M3MYTD1Y3Y5Y
Perf.
PBPH
IXJ
-1.83%-1.05%
-5.37%-7.69%
-2.73%-6.67%
n/a+4.32%
n/a+9.37%
n/a+21.59%
Flows
PBPH
IXJ
+$39M+$19M
+$757M-$888M
+$787M-$729M
--$450M
--$1.07B
-+$205M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBPH
IXJ
+16.32%+15.16%
n/a+15.42%
n/a+13.25%
n/a+13.95%
Max drawdown
PBPH
IXJ
-9.94%-10.83%
n/a-10.83%
n/a-18.04%
n/a-18.04%
Max drawdown duration
PBPH
IXJ
70d59d
n/a59d
n/a490d
n/a490d
Trading data

Create an account to view trading data

Join for free
PBPH
IXJ
Last sale
4/30/2026 at 7:12 PM
$25.10
$92.91
Previous close
04/29/2026
$24.30
$90.75
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PBPH
IXJ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/30/2026 at 7:12 PM
Live
Closed
PBPH
IXJ
Last price
$25.10
$92.91
1D performance
+3.30%
+2.38%
AuM$725.81 M$3.53 B
E/R0.13%0.4%
Characteristics
PBPH
IXJ
Management strategyPassivePassive
ProviderTidaliShares
BenchmarkBITA Global Pharma and Biotech Select IndexS&P Global 1200 Health Care (Sector) Capped Index
N° of holdings49104
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 24, 2025November 13, 2001
ESGNoNo
Advertisement
Exposure

Countries

PBPH
USA
63.05%
Switzerland
10.48%
Other
26.47%
IXJ
USA
68.5%
Switzerland
10.22%
Other
21.28%

Sectors

PBPH
Health Care
85.65%
Other
14.35%
IXJ
Health Care
90.51%
Other
9.49%

Diversification

PBPH

Total weight of top 15 holdings out of 15

71.34%
IXJ

Total weight of top 15 holdings out of 15

56.56%

Top 15 holdings

Data as of March 31, 2026
PBPH
LILLY
12.31%
JOHNSON&JOHNSON
9.59%
ABBVIE
6.19%
MERCK & CO INC
4.79%
NOVARTIS
4.64%
CH1499059983
4.47%
GILEAD SCIENCES
4.42%
AMGEN-T
4.38%
PFIZER
4.13%
BRISTOL-MYERS SQUIBB
3.18%
DK0062498333
2.96%
VERTEX PHARMACEUTICALS
2.94%
SANOFI SA
2.68%
GSK PLC
2.67%
REGENERON PHARMACEUTICALS
2.00%
IXJ
LILLY
9.50%
JOHNSON&JOHNSON
7.68%
ABBVIE
5.01%
ASTRAZENECA
4.01%
MERCK & CO INC
3.98%
NOVARTIS
3.81%
CH1499059983
3.67%
UNITEDHEALTH GRP
3.27%
AMGEN-T
2.53%
THERMO FISHER SCIENTIFIC
2.46%
ABBOTT LABS
2.38%
GILEAD SCIENCES
2.31%
INTUITIVE SURGICAL
2.18%
PFIZER
2.13%
BRISTOL-MYERS SQUIBB
1.65%
Frequently asked questions about PBPH and IXJ

How have the PBPH and IXJ ETFs performed in 2026?

As of April 28, 2026, PBPH is down -2.73% year-to-date (YTD), while IXJ has lost -6.67%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or IXJ?

Year-to-date, the PBPH ETF saw +$787M in flows, compared to -$729M for IXJ.

Which ETF is bigger: PBPH or IXJ?

As of April 28, 2026, PBPH holds $725.81 M in assets under management (AUM), while IXJ manages $3.53 B.

What sectors do the PBPH and IXJ ETFs invest in?

PBPH leans toward sectors like Health Care. Meanwhile, IXJ focuses on Health Care.

What are the top holdings of the PBPH ETF and IXJ ETF?

PBPH top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. IXJ holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: PBPH or IXJ?

PBPH holds 52 securities with 71.34% of its assets in the top 15. IXJ has 114 securities and a top 15 weight of 56.56%.

Advertisement
Latest news about PBPH & IXJ
Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast